Surterra Texas™ Launches First Medical Cannabis Gummies for the Texas Compassionate Use Program
New cannabis-infused gummies provide Texas patients with conveniently-administered doses of THC and CBD for conditions such as terminal cancer, spasticity, autism, epilepsy, and incurable neurological diseases
News provided by
Share this article
Share this article
AUSTIN, Texas, Jan. 26, 2021 /PRNewswire/ -- Surterra Texas, a division of the privately-held, multi-state, cannabis company Parallel and a leading medical cannabis company, today announced the availability of the first cannabis-infused gummies for patients in Texas. This introduction of gummies further expands Surterra Texas' market-leading product portfolio, providing Texans with the state's largest assortment of cannabis-based medicines and product formats.